Cytogenetics can inform risk stratification in pediatric acute myeloid leukemia (AML). We
describe the first case of a newborn with leukemia cutis found to have AML harboring a …

We present the nonrandom occurrence, frequency, and degree of immunophenotype
association of the t (1; 22)(p13; q13) in children with acute nonlymphocytic leukemia (ANLL) …

Acute undifferentiated leukemia (AUL) is a very rare hematologic neoplasm that expresses
no markers specific for either myeloid or lymphoid lineages. While commonly observed in …

Infant leukemias are a rare group of neoplasms that are clinically and biologically distinct
from their pediatric and adult counterparts. Unlike leukemia in older children where survival …

Objectives Acute myeloid leukemia (AML) with t (8; 16)(p11; p13) abnormalities is a rare,
aggressive, and diagnostically challenging subtype that results in KAT6A-CREBBP gene …

Abstract Introduction: The translocation, t (8; 16)(p11; p13), results in the fusion between
KAT6A and CREBBP and has been associated with a poor prognosis in both pediatric and …

Introduction Translocations involving the KMT2A gene (also known as MLL) are frequently
diagnosed in pediatric acute leukemia cases with either lymphoblastic or myeloid origin …

Using both conventional and molecular cytogenetic methods, we found five new cases of t
(10; 11)(p12; q23). This translocation represented 28% of all cases of childhood AML treated …

Abstract t (8; 16)(p11. 2; p13. 3)/KAT6A-CREBBP is a rare recurrent cytogenetic abnormality
associated with acute myeloid leukemia (AML). We report 15 cases with t (8; 16)(p11. 2; p13 …

Introduction: Currently, most phenotypic, cytogenetic or molecular markers identified in
children with acute myeloid leukemia (AML) are not used for risk stratification or treatment …